PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Subdivisions of Program Areas, these track general higher level sub-classifications of expenditure.
Subdivisions of Major categories, these are the most detailed expenditure data.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2010
The purpose of this mechanism is to enable the USG Caribbean laboratory working group to collaborate with key resource persons including staff of the Global AIDS Program International Laboratory Branch (ILB) at CDC Atlanta, USG colleagues from other PEPFAR countries and non-USG partners. This mechanism will support these key resource persons to visit the region as consultants and assist in implementing technical laboratory services and systems including execution of laboratory operational studies. This mechanism will also support consultancy fees for non-USG consultants, costs of shipping patients samples to CDC Atlanta for analysis, and travel for laboratory scientists from the Caribbean Region countries where the samples are collected to Atlanta and/or other laboratories to participate in the analysis and generation of data from these samples. Governments within the region have expressed the need for data from laboratory operational studies to improve current laboratory services and support various cross-cutting activities.
This implementing mechanism is in direct support of the USG Caribbean Partnership Framework Laboratory System Goal 3 (objective 3.2: Improve laboratory services and systems).
This mechanism will build the capacity of Caribbean region laboratory staff and will facilitate generation of laboratory operational data to inform services and lab policy. The training of young scientists through these studies will support sustainable national infrastructure, workforce capacity and expanded services to provide quality diagnostic testing, clinical laboratory monitoring of treatment, and surveillance.
This CDC Central Laboratory Support mechanism will be used to request technical assistance (TA) on a short term consultancy basis to provide training and other assistance to implement the following activities: development of HIV rapid testing algorithms and training and roll-out of HIV rapid testing. Successful training and roll out of rapid testing will include cost effective quality assurance activities utilizing Dried Tube Specimen (DTS) technology, and use standardized logbooks at all HIV testing sites. This mechanism will also support other onsite supervision and training such as GCLP, quality management, HIV drug resistance set-up, and regional and national TB QA/QC programs.
This mechanism will also support laboratory operational studies to address key questions within the region, such as:
Determining HIV incidence using the BED testing of archived HIV positive and negative samples from Jamaica, Bahamas and Trinidad and Tobago, the highest HIV prevalence countries within the 12-country region. This information will provide critical information on current transmission trends and patterns for HIV surveillance and will therefore inform HIV prevention interventions.
Determining HIV genetic subtypes and drug resistance using archived samples from Jamaica, Bahamas, Trinidad and Tobago and Barbados. This will provide vital information particularly on current HIV heterogeneity, which has implications for treatment, diagnosis, and vaccine development. The drug resistance data is vital particularly for the prevalence of primary HIV drug resistance and its public health implications.
Evaluation of the oral fluid based HIV rapid test kits, as they have been shown to be more user friendly for HIV rapid testing.
Evaluation of the most appropriate Point-Of-Care CD4 machine. The Caribbean region seeks to select common CD4 platforms that will streamline maintenance and procurement.
This mechanism will support the purchase of reagents and other consumables as well as travel of laboratory scientists to carry out these studies.